companiesandmarkets.com


Martek Biosciences Corp - Premium Company Profile

http://www.companiesandmarkets.com/Summary-Company-Profile/martek-biosciences-corp-premium-company-profile-41363.asp


Report Summary

Introduction

Martek Biosciences (Martek) is a life-science based company that develops and commercializes naturally produced products derived from microalgae, fungi and other microbes. It's research is focused on identifying and creating commercially viable products for the nutraceutical, pharmaceutical and functional foods markets.

Scope

  • Contains corporate strategy, value chain presence and SWOT Analysis
  • Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
  • Includes information on suppliers/ partners, shareholding structure and key employees with biographies


  • Highlights

    Martek's product focus is the development of nutritional products derived from microalgae, fungi and other microbes for the treatment of diseases in the area of inflammation, cognitive function and cardiovascular health. It has developed and patented two fermentable strains of microalgae which produce oils rich in docosahexaenoic acid (DHA).

    A similar patented process was developed for a fungus that produces an oil rich in arachidonic acid, ARA. Both DHA and ARA are important nutrients for optimal infant development. It's product folio includes Neuromins brand DHA supplements containing life'sDHA is a vegetarian source of docosahexaenoic acid, DHA for pregnant women.

    Martek derives majority of its revenues from the product sales of infant formula that contains nutritional oils as well as from the product sales of Neuromins, a DHA dietary supplement. It also generates revenues through contract manufacturing for the production of enzymes, specialty chemicals, vitamins and agricultural specialty products.

    Reasons to Purchase

  • Access all the important information and analysis on the company in a single report
  • Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
  • Gain access to company's adjusted five year financial data along with key ratios and market capitalization

  • Table of Contents

    TABLE OF CONTENTS
    Overview 1
    Catalyst 1
    Summary 1
    Company Structure 7
    Company Overview and Key Facts 7
    Business Description 8
    History 10
    Locations and Subsidiaries 13
    Company Financials 14
    Stock Market Performance 14
    P&L 15
    Balance Sheet 18
    Cash Flow 18
    Business Segment Performance 19
    Products & Services 21
    Marketed Products 21
    Competitors and Strategic Business Relationships 22
    Top Competitors 22
    Key Suppliers 23
    Key Clients 23
    Shareholding Structure 24
    Strategy 25
    Company View 25
    Corporate Strategy 28
    SWOT Analysis 30
    Overview 30
    Strengths 31
    Weaknesses 33
    Opportunities 34
    Threats 35
    Value Chain Analysis 36
    Overview 36
    Discovery and Product Development 37
    Manufacturing 37
    Sales 37
    Key Employees 38
    List of Key Employees 38
    Key Employee Biographies 39
    Financial and Operational Overview 45
    Financial and Operational Overview 45
    Appendix 47
    Ask the analyst 47
    Datamonitor consulting 47
    Disclaimer 47


    TABLE OF FIGURES
    Figure 1: Martek Biosciences - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 16
    Figure 2: Martek Biosciences - Key Strategic Revenues, 2002-2006 ($ Mn) 20


    TABLE OF TABLES
    Table 1: Martek Biosciences - Key Facts 7
    Table 2: Martek Biosciences – Other Locations and Subsidiaries 13
    Table 3: Martek Biosciences - Year-End Share Price and Market Capitalization, 2002-2006 ($) 14
    Table 4: Martek Biosciences - Key Events Impacting Share Price Performance 14
    Table 5: Martek Biosciences - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
    Table 6: Martek Biosciences - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 17
    Table 7: Martek Biosciences - Balance Sheet, 2002-2006 ($ Mn) 18
    Table 8: Martek Biosciences - Cash Flow, 2002-2006 ($ Mn) 18
    Table 9: Martek Biosciences - Revenue Breakdown, 2002-2006 ($ Mn) 19
    Table 10: Martek Biosciences – Marketed Products 21
    Table 11: Martek Biosciences – Top Competitors 22
    Table 12: Martek Biosciences – Key Clients 23
    Table 13: Martek Biosciences - Key Shareholders 24
    Table 14: Martek Biosciences - SWOT Analysis Summary 30
    Table 15: Martek Biosciences – Value Chain Analysis 36
    Table 16: Martek Biosciences - Key Employees 38
    Table 17: Martek Biosciences - Financial and Operational Overview 45